Smiths Group Plc SMIN

Smiths Group is back in focus after a cluster of new price targets, ranging from 2,675 GBp to 3,150 GBp, reset expectations around what the shares might be worth. These targets reflect a split analyst view, with some highlighting margin potential and capital returns, and others pointing to execution risks and a share price that already tracks close to fair value. Read on to see what is driving these calls and how you can keep on top of the evolving Smiths Group story. Analyst Price Targets...

Smiths Group PLC (SMGKF) delivered 1.2% organic revenue growth, a 20.6% headline operating margin, and guided FY27 margin to approximately 21%, entering its target range sooner than expected.

Smiths Group (LON:SMIN) reported organic revenue growth and margin expansion for fiscal 2026 while completing a major portfolio reshaping that left the company focused on its John Crane and Flex-Tek businesses. The company said it completed the sales of Smiths Interconnect and Smiths Detection, rea

LONDON, July 13, 2026 (GLOBE NEWSWIRE) -- John Crane, a global leader in flow control technologies and a business of Smiths Group plc, has achieved Broad-Based Black Economic Empowerment (B-BBEE) Level One contributor status in South Africa, marking a significant strategic milestone for the company’s long-term growth, localisation and customer support strategy across the region. The certification, awarded following John Crane South Africa’s strategic partnership with the Bunengi Group, positions

LONDON, July 02, 2026-- Young & Co.'s Brewery, P.L.C. ("Young’s")

Price targets for Smiths Group have seen only modest adjustments, with JPMorgan trimming its target from £28.30 to £28.10 while more cautious analysts have moved from £29.00 to £27.50. These shifts align with a more measured Street stance, where some focus on long term execution potential and others are waiting for clearer evidence from upcoming trading updates before assigning higher targets. As you read on, you will see how these moves fit into the evolving analyst narrative around Smiths...

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Neonatal Intensive Care Respiratory Devices Market size & share revenue was valued at approximately USD 2.1 Billion in 2025 and is expected to reach USD 2.3 Billion in 2026 and is expected to reach around USD 5.7 Billion by 2035, at a CAGR of 10.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Inspirat

Smiths Group (LON:SMIN) lowered its full-year organic revenue growth outlook after Middle East-related disruption weighed on its John Crane business in the third quarter, Chief Financial Officer Julian Fagge said on the company’s Q3 2026 trading update call. Fagge said Smiths’ organic revenue was f

SAN RAMON, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Paul Keel as an independent director, effective July 1, 2026. Mr. Keel has also been appointed to serve on the Audit Committee when he joins the Board. “We are delighted to welcome Paul to our Board as a new Director,” said Colleen Jay, Chair of the Board of CooperCompanies. “His experience as a CEO in the medical de

Smiths Group (LON:SMIN) used a recent investor presentation hosted by Engage Investor to outline its plan to become a more focused industrial engineering company centered on John Crane and Flex-Tek, following the agreed divestments of Smiths Interconnect and Smiths Detection. The presentation was le

Recent price target moves on Smiths Group have pulled in opposite directions, with bullish analysts lifting targets by 90 GBp and 100 GBp, while others have reset expectations closer to 2,700 GBp. These changes reflect a split in the analyst community, where some houses see upside based on Smiths Group’s prospects and others highlight growth risks and potential execution issues. Read on to see what is driving this evolving narrative and how you can track it over time. Stay updated as the Fair...

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Anesthesia and Respiratory Devices Market size & share revenue was valued at approximately USD 57.2 Billion in 2025 and is expected to reach USD 60.5 Billion in 2026 and is expected to reach around USD 100.5 Billion by 2035, at a CAGR of 5.8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Medtronic, O2

Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Smiths Interconnect, a subsidiary of United Kingdom-based Smiths Group plc, marking a major milestone in Molex's vision to enable technology that is transforming the future and improving people's lives. Smiths Interconnect brings a diverse portfolio of complementary products and advantaged capabilities in ruggedized custom connectors, contacts, RF components and optical transceivers for harsh environm

Smiths Group PLC (SMGKF) reports robust financial performance with significant profit growth, strategic acquisitions, and a substantial shareholder return program.

Smiths Group (LON:SMIN) leaders used the company’s fiscal 2026 first-half earnings call to emphasize the strategic reshaping of the portfolio, including agreed sales of Smiths Interconnect and Smiths Detection, while reporting solid underlying performance and reiterating expectations for a stronger